Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Johnson

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Nature Medicine|November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
The Journal of Infectious Diseases|January 29, 2003
Whole blood bactericidal activity during treatment of pulmonary tuberculosisRobert S Wallis, Solange A Vinhas, John L Johnson, et al.
Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Tuberculosis (Edinburgh, Scotland)|March 18, 2014
Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosisPayam Nahid, Erin Bliven-Sizemore, Leah G Jarlsberg, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2018
Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulationJames Millard, Henry Pertinez, Laura Bonnett, et al.
Frontiers in Immunology|April 18, 2022
Durable Expansion of TCR-δ Meta-Clonotypes After BCG Revaccination in HumansCharlotte A James, Krystle K Q Yu, Koshlan Mayer-Blackwell, et al.
Journal of Clinical Immunology|September 1, 2005
Mechanisms of apoptosis of T-cells in human tuberculosisChristina S Hirsch, John L Johnson, Alphonse Okwera, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2006
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosisWilliam J Burman, Stefan Goldberg, John L Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|April 19, 2003
Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosisJohn L Johnson, Emmanuel Ssekasanvu, Alphonse Okwera, et al.
Cancer Detection and Prevention|April 15, 2005
Capacity building for the clinical investigation of AIDS malignancy in East AfricaJackson Orem, Mwanda W Otieno, Cecily Banura, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Nature Medicine|November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
The Journal of Infectious Diseases|January 29, 2003
Whole blood bactericidal activity during treatment of pulmonary tuberculosisRobert S Wallis, Solange A Vinhas, John L Johnson, et al.
Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Tuberculosis (Edinburgh, Scotland)|March 18, 2014
Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosisPayam Nahid, Erin Bliven-Sizemore, Leah G Jarlsberg, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2018
Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulationJames Millard, Henry Pertinez, Laura Bonnett, et al.
Frontiers in Immunology|April 18, 2022
Durable Expansion of TCR-δ Meta-Clonotypes After BCG Revaccination in HumansCharlotte A James, Krystle K Q Yu, Koshlan Mayer-Blackwell, et al.
Journal of Clinical Immunology|September 1, 2005
Mechanisms of apoptosis of T-cells in human tuberculosisChristina S Hirsch, John L Johnson, Alphonse Okwera, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2006
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosisWilliam J Burman, Stefan Goldberg, John L Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|April 19, 2003
Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosisJohn L Johnson, Emmanuel Ssekasanvu, Alphonse Okwera, et al.
Cancer Detection and Prevention|April 15, 2005
Capacity building for the clinical investigation of AIDS malignancy in East AfricaJackson Orem, Mwanda W Otieno, Cecily Banura, et al.
Pageof 11